FERMENTA BIOTECH
|
FERMENTA BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 26.35 | -7.99 | -17.70 | 5.35 | 15.77 |
| CEPS(Rs) | 34.50 | 0.25 | -8.62 | 14.08 | 21.78 |
| DPS(Rs) | 2.50 | 1.25 | 1.25 | 1.25 | 2.50 |
| Book NAV/Share(Rs) | 124.23 | 95.63 | 104.67 | 123.91 | 120.84 |
| Tax Rate(%) | 8.18 | -143.18 | -3.56 | 44.10 | 17.63 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.54 | 8.31 | 5.20 | 15.62 | 21.89 |
| EBIT Margin(%) | 20.90 | 2.25 | -8.55 | 11.27 | 18.72 |
| Pre Tax Margin(%) | 17.72 | -2.94 | -14.66 | 6.76 | 13.68 |
| PAT Margin (%) | 16.27 | -7.15 | -15.18 | 3.78 | 11.27 |
| Cash Profit Margin (%) | 21.43 | 0.21 | -7.11 | 10.19 | 16.66 |
| Performance Ratios | |||||
| ROA(%) | 12.85 | -4.01 | -7.63 | 2.04 | 6.56 |
| ROE(%) | 23.93 | -8.30 | -16.11 | 4.27 | 13.05 |
| ROCE(%) | 21.97 | 1.58 | -5.25 | 7.50 | 12.62 |
| Asset Turnover(x) | 0.79 | 0.56 | 0.50 | 0.54 | 0.58 |
| Sales/Fixed Asset(x) | 1.24 | 0.93 | 1.08 | 1.25 | 1.52 |
| Working Capital/Sales(x) | 3.81 | 4.90 | 7.90 | 3.73 | 3.76 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.80 | 1.08 | 0.93 | 0.80 | 0.66 |
| Receivable days | 64.16 | 60.61 | 67.14 | 71.03 | 66.65 |
| Inventory Days | 82.04 | 118.27 | 151.04 | 147.34 | 140.69 |
| Payable days | 176.30 | 155.24 | 131.18 | 150.99 | 160.90 |
| Valuation Parameters | |||||
| PER(x) | 10.38 | - | - | 38.41 | 15.87 |
| PCE(x) | 7.93 | 615.28 | -12.40 | 14.61 | 11.49 |
| Price/Book(x) | 2.20 | 1.58 | 1.02 | 1.66 | 2.07 |
| Yield(%) | 0.91 | 0.83 | 1.17 | 0.61 | 1.00 |
| EV/Net Sales(x) | 1.78 | 1.52 | 1.33 | 2.00 | 2.40 |
| EV/Core EBITDA(x) | 6.83 | 12.84 | 17.44 | 11.29 | 9.97 |
| EV/EBIT(x) | 8.52 | 67.47 | -15.61 | 17.72 | 12.84 |
| EV/CE(x) | 1.77 | 1.21 | 0.88 | 1.06 | 1.26 |
| M Cap / Sales | 1.70 | 1.30 | 0.88 | 1.49 | 1.91 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 39.87 | -4.08 | -12.19 | 5.63 | 28.79 |
| Core EBITDA Growth(%) | 208.12 | 48.17 | -61.99 | -22.50 | 15.84 |
| EBIT Growth(%) | 1,198.94 | 125.23 | -166.63 | -36.40 | 11.22 |
| PAT Growth(%) | 418.23 | 54.81 | -452.79 | -64.59 | -28.54 |
| EPS Growth(%) | 429.95 | 54.88 | -430.53 | -66.06 | -23.55 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.30 | 0.48 | 0.72 | 0.66 | 0.66 |
| Current Ratio(x) | 1.50 | 1.35 | 1.19 | 1.47 | 1.44 |
| Quick Ratio(x) | 1.00 | 0.90 | 0.63 | 0.77 | 0.73 |
| Interest Cover(x) | 6.59 | 0.43 | -1.40 | 2.50 | 3.72 |
| Total Debt/Mcap(x) | 0.14 | 0.30 | 0.69 | 0.39 | 0.31 |
Compare Financial Ratios of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹933.6 Cr | -5.5% | -14.1% | 9.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
| CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | -5.5% |
-14.1% |
9.2% |
| SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses
